173897-93-3 Usage
Uses
Used in Pharmaceutical Industry:
(R)-benzyl 1-(4-(1H-pyrrolo[2,3-b]pyridin-4-ylcarbaMoyl)phenyl)ethylcarbaMate is used as a therapeutic agent for the treatment of cognitive disorders such as Alzheimer's disease and attention-deficit hyperactivity disorder (ADHD). It is employed for its ability to improve cognitive function and memory, as demonstrated in preclinical studies.
Used in Neurological Research:
(R)-benzyl 1-(4-(1H-pyrrolo[2,3-b]pyridin-4-ylcarbaMoyl)phenyl)ethylcarbaMate is used as a research tool to study the role of histamine H3 receptors in cognitive function and synaptic plasticity. Its ability to enhance neurotransmitter release in the brain makes it a valuable compound for investigating the underlying mechanisms of cognitive impairment and potential treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 173897-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,8,9 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 173897-93:
(8*1)+(7*7)+(6*3)+(5*8)+(4*9)+(3*7)+(2*9)+(1*3)=193
193 % 10 = 3
So 173897-93-3 is a valid CAS Registry Number.
173897-93-3Relevant academic research and scientific papers
VISUAL FUNCTION DISORDER IMPROVING AGENTS
-
, (2016/09/12)
The present invention provides a visual function disorder improving agent containing a compound having Rho kinase inhibitory activity, particularly (R)-(+)-N-(1H-pyrrolo?2,3-büpyridin-4-yl)-4-(1-aminoethyl)benzamide, as an effective component. This agent
N-heterocyclic substituted benzamide derivatives with antihypertensive activity
-
Page 52-53, (2008/06/13)
Benzamide compounds of the formula wherein each symbol is as defined in the specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. Pharmaceutical compositions comprising a therapeutically effective amount of this compo
Benzamide compounds and pharmaceutical use thereof
-
, (2008/06/13)
Benzamide compounds of the formula STR1 wherein each symbol is as defined in the specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. Pharmaceutical compositions comprising a therapeutically effective amount of this
